Li, J. and Peng, L. and Wu, L. and Kuang, Y. and Su, J. and Yi, M. and Hu, X. and Li, D. and Xie, H. and Kanekura, T. and Chen, X.
doi:10.1016/j.jdermsci.2010.03.022
Abstract
Increased sensitivity to reactive oxygen species (ROS) contributes to the effectiveness of therapeutic strategies in patients with malignant melanoma (MM). CD147, a cell surface receptor for cyclophilin A (CypA), is thought to exert antioxidant activities.